Figure 5 B-b.
Heterogeneity indicators for the outcome of “infectious complication” in the clinical trials considering IFX vs. placebo therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.